Modulation of tumor tolerance in primary central nervous system malignancies

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Johnson, Theodore S ^a   Munn, David H ^a   Maria, Bernard L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL DEXTRO TRYPTOPHAN; ANGIOGENESIS INHIBITOR; ANTIGEN; BEVACIZUMAB; CYTOKINE; GROWTH FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; IPILIMUMAB; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BONE MARROW CELL; CANCER GROWTH; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CENTRAL NERVOUS SYSTEM TUMOR; DENDRITIC CELL; ENZYME ACTIVITY; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MICROGLIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; ANIMAL; CENTRAL NERVOUS SYSTEM; CHILD; IMMUNOLOGY; MOUSE; PATHOLOGY; PRESCHOOL CHILD;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNE TOLERANCE; MICE;

EID: 84858212485     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/937253     Document Type: Review

References (147)

1. Howlader N., Noone A. M., Krapcho M., SEER Cancer Statistics Review 19752008 2011 Bethesda, Md, USA National Cancer Institute. http://seer.cancer. gov/csr/19752008/
2. Section 28: Childhood Cancer by Site, 019 Year Old Age Group National Cancer Institute Surveillance Epidemiology and End Results (SEER), Cancer Statistics Review 19752007
3. Lai A., Tran A., Nghiemphu P. L., Pope W. B., Solis O. E., Selch M., Filka E., Yong W. H., Mischel P. S., Liau L. M., Phuphanich S., Black K., Peak S., Green R. M., Spier C. E., Kolevska T., Polikoff J., Fehrenbacher L., Elashoff R., Cloughesy T., Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme Journal of Clinical Oncology 2011 29 2 142 148
4. Lin A. A., Tripathi P. K., Sholl A., Jordan M. B., Hildeman D. A., Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production Journal of Virology 2009 83 17 8604 8615
5. Zhu X., Fallert-Junecko B. A., Fujita M., Ueda R., Kohanbash G., Kastenhuber E. R., McDonald H. A., Liu Y., Kalinski P., Reinhart T. A., Salazar A. M., Okada H., Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN- and IFN- dependent manners Cancer Immunology, Immunotherapy 2010 59 9 1401 1409
6. Kishimoto H., Sprent J., Negative selection in the thymus includes semimature T cells Journal of Experimental Medicine 1997 185 2 263 271 (Pubitemid 27078283)
7. Miyara M., Sakaguchi S., Natural regulatory T cells: mechanisms of suppression Trends in Molecular Medicine 2007 13 3 108 116 (Pubitemid 46341958)
8. Jordan M. S., Boesteanu A., Reed A. J., Petrone A. L., Holenbeck A. E., Lerman M. A., Naji A., Caton A. J., Thymic selection of CD4 + CD25 + regulatory T cells induced by an agonist self-peptide Nature Immunology 2001 2 4 301 306 (Pubitemid 33706340)
9. Haribhai D., Williams J. B., Jia S., Nickerson D., Schmitt E. G., Edwards B., Ziegelbauer J., Yassai M., Li S. -H., Relland L. M., Wise P. M., Chen A., Zheng Y. -Q., Simpson P. M., Gorski J., Salzman N. H., Hessner M. J., Chatila T. A., Williams C. B., A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity Immunity 2011 35 1 109 122
10. Thompson L. J., Valladao A. C., Ziegler S. F., Cutting edge: de novo induction of functional Foxp3 + regulatory CD4 T cells in response to tissue-restricted self antigen Journal of Immunology 2011 186 8 4551 4555
11. Peggs K. S., Quezada S. A., Allison J. P., Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy Immunological Reviews 2008 224 1 141 165
12. von Boehmer H., Mechanisms of suppression by suppressor T cells Nature Immunology 2005 6 4 338 344 (Pubitemid 41716770)
13. Gorelik L., Flavell R. A., Immune-mediated eradication of tumors through the blockade of transforming growth factor- signaling in T cells Nature Medicine 2001 7 10 1118 1122 (Pubitemid 33010019)
14. Munn D. H., Shafizadeh E., Attwood J. T., Bondarev I., Pashine A., Mellor A. L., Inhibition of T cell proliferation by macrophage tryptophan catabolism Journal of Experimental Medicine 1999 189 9 1363 1372 (Pubitemid 29227522)
15. Attwood J. T., Munn D. H., Macrophage suppression of T cell activation: a potential mechanism of peripheral tolerance International Reviews of Immunology 1999 18 5-6 515 525 (Pubitemid 30028079)
16. Munn D. H., Sharma M. D., Lee J. R., Jhaver K. G., Johnson T. S., Keskin D. B., Marshall B., Chandler P., Antonia S. J., Burgess R., Slingluff C. L., Mellor A. L., Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 2002 297 5588 1867 1870 (Pubitemid 35024345)
17. Munn D. H., Zhou M., Attwood J. T., Bondarev I., Conway S. J., Marshall B., Brown C., Mellor A. L., Prevention of allogeneic fetal rejection by tryptophan catabolism Science 1998 281 5380 1191 1193 (Pubitemid 28406294)
18. Mellor A. L., Keskin D. B., Johnson T., Chandler P., Munn D. H., Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses Journal of Immunology 2002 168 8 3771 3776 (Pubitemid 34298376)
19. Baban B., Chandler P., McCool D., Marshall B., Munn D. H., Mellor A. L., Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific Journal of Reproductive Immunology 2004 61 2 67 77 (Pubitemid 38446980)
20. Baban B., Chandler P. R., Sharma M. D., Pihkala J., Koni P. A., Munn D. H., Mellor A. L., IDO activates regulatory T cells and blocks their conversion into Th17-like T cells Journal of Immunology 2009 183 4 2475 2483
21. Baban B., Hansen A. M., Chandler P. R., Manlapat A., Bingaman A., Kahler D. J., Munn D. H., Mellor A. L., A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation International Immunology 2005 17 7 909 919 (Pubitemid 41417958)
22. Mellor A. L., Chandler P., Baban B., Hansen A. M., Marshall B., Pihkala J., Waldmann H., Cobbold S., Adams E., Munn D. H., Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase International Immunology 2004 16 10 1391 1401 (Pubitemid 39341552)
23. Fallarino F., Vacca C., Orabona C., Belladonna M. L., Bianchi R., Marshall B., Keskin D. B., Mellor A. L., Fioretti M. C., Grohmann U., Puccetti P., Functional expression of indoleamine 2,3-dioxygenase by murine CD8 + dendritic cells International Immunology 2002 14 1 65 68 (Pubitemid 34083398)
24. Grohmann U., Volpi C., Fallarino F., Bozza S., Bianchi R., Vacca C., Orabona C., Belladonna M. L., Ayroldi E., Nocentini G., Boon L., Bistoni F., Fioretti M. C., Romani L., Riccardi C., Puccetti P., Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy Nature Medicine 2007 13 5 579 586 (Pubitemid 46828479)
25. Coquerelle C., Oldenhove G., Acolty V., Denoeud J., Vansanten G., Verdebout J. M., Mellor A., Bluestone J. A., Moser M., Anti-CTLA-4 treatment induces IL-10-producing ICOS + regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis Gut 2009 58 10 1363 1373
26. Raftery M. J., Wieland D., Gronewald S., Kraus A. A., Giese T., Schnrich G., Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10 Journal of Immunology 2004 173 5 3383 3391 (Pubitemid 39142048)
27. Gorelik L., Flavell R. A., Transforming growth factor- in T-cell biology Nature Reviews Immunology 2002 2 1 46 53 (Pubitemid 37328775)
28. Mitchell D. A., Fecci P. E., Sampson J. H., Immunotherapy of malignant brain tumors Immunological Reviews 2008 222 1 70 100 (Pubitemid 351430365)
29. Engelhardt B., Ransohoff R. M., The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms Trends in Immunology 2005 26 9 485 495 (Pubitemid 41139258)
30. Hatterer E., Davoust N., Didier-Bazes M., Vuaillat C., Malcus C., Belin M. F., Nataf S., How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes Blood 2006 107 2 806 812 (Pubitemid 43076409)
31. Weller R. O., Galea I., Carare R. O., Minagar A., Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis Pathophysiology 2010 17 4 295 306
32. Hochmeister S., Zeitelhofer M., Bauer J., Nicolussi E. M., Fischer M. T., Heinke B., Selzer E., Lassmann H., Bradl M., After injection into the striatum, in vitro-differentiated microglia- and bone marrow-derived dendritic cells can leave the central nervous system via the blood stream The American Journal of Pathology 2008 173 6 1669 1681
33. Harling-Berg C. J., Park J. T., Knopf P. M., Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation Journal of Neuroimmunology 1999 101 2 111 127 (Pubitemid 29516453)
34. Rezai-Zadeh K., Gate D., Town T., CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease? Journal of Neuroimmune Pharmacology 2009 4 4 462 475
35. Fabry Z., Schreiber H. A., Harris M. G., Sandor M., Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation Current Opinion in Pharmacology 2008 8 4 496 507
36. Nimmerjahn A., Kirchhoff F., Helmchen F., Neuroscience: resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo Science 2005 308 5726 1314 1318 (Pubitemid 40746128)
37. Guillemin G. J., Brew B. J., Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification Journal of Leukocyte Biology 2004 75 3 388 397 (Pubitemid 38316367)
38. Mrass P., Weninger W., Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors Immunological Reviews 2006 213 1 195 212 (Pubitemid 44401502)
39. Kaur G., Han S. J., Yang I., Crane C., Microglia and central nervous system immunity Neurosurgery Clinics of North America 2010 21 1 43 51
40. Gimsa U., ren A., Pandiyan P., Teichmann D., Bechmann I., Nitsch R., Brunner-Weinzierl M. C., Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152) Journal of Molecular Medicine 2004 82 6 364 372 (Pubitemid 38887866)
41. Kwidzinski E., Bunse J., Kovac A. D., Ullrich O., Zipp F., Nitsch R., Bechmann I., IDO (indolamine 2,3-dioxygenase) expression and function in the CNS Advances in Experimental Medicine and Biology 2003 527 113 118 (Pubitemid 38197635)
42. Mellor A. L., Munn D. H., Creating immune privilege: active local suppression that benefits friends, but protects foes Nature Reviews Immunology 2008 8 1 74 80
43. Darrasse-Jze G., Bergot A. S., Durgeau A., Billiard F., Salomon B. L., Cohen J. L., Bellier B., Podsypanina K., Klatzmann D., Tumor emergence is sensed by self-specific CD 44 hi memory Tregs that create a dominant tolerogenic environment for tumors in mice Journal of Clinical Investigation 2009 119 9 2648 2662
44. Munn D. H., Indoleamine 2,3-dioxygenase, Tregs and cancer Current Medicinal Chemistry 2011 18 15 2240 2246
45. Sharma M. D., Hou D. Y., Baban B., Koni P. A., He Y., Chandler P. R., Blazar B. R., Mellor A. L., Munn D. H., Reprogrammed Foxp3 + Regulatory T Cells Provide Essential Help to Support Cross-presentation and CD8 + T Cell Priming in Naive Mice Immunity 2010 33 6 942 954
46. Francisco L. M., Salinas V. H., Brown K. E., Vanguri V. K., Freeman G. J., Kuchroo V. K., Sharpe A. H., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells Journal of Experimental Medicine 2009 206 13 3015 3029
47. Sharma M. D., Baban B., Chandler P., Hou D. Y., Singh N., Yagita H., Azuma M., Blazar B. R., Mellor A. L., Munn D. H., Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase Journal of Clinical Investigation 2007 117 9 2570 2582 (Pubitemid 47494358)
48. Sharma M. D., Hou D. Y., Liu Y., Koni P. A., Metz R., Chandler P., Mellor A. L., He Y., Munn D. H., Indoleamine 2,3-dioxygenase controls conversion of Foxp3 + Tregs to TH17-like cells in tumor-draining lymph nodes Blood 2009 113 24 6102 6111
49. Muller A. J., Sharma M. D., Chandler P. R., DuHadaway J. B., Everhart M. E., Johnson B. A., Kahler D. J., Pihkala J., Soler A. P., Munn D. H., Prendergast G. C., Mellor A. L., Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3-dioxygenase Proceedings of the National Academy of Sciences of the United States of America 2008 105 44 17073 17078
50. Uyttenhove C., Pilotte L., Théate I., Stroobant V., Colau D., Parmentier N., Boon T., Van den Eynde B. J., Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nature Medicine 2003 9 10 1269 1274 (Pubitemid 37279849)
51. Hou D. Y., Muller A. J., Sharma M. D., DuHadaway J., Banerjee T., Johnson M., Mellor A. L., Prendergast G. C., Munn D. H., Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses Cancer Research 2007 67 2 792 801 (Pubitemid 46192220)
52. Muller A. J., DuHadaway J. B., Donover P. S., Sutanto-Ward E., Prendergast G. C., Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy Nature Medicine 2005 11 3 312 319 (Pubitemid 40460560)
53. Muller A. J., Duhadaway J. B., Jaller D., Curtis P., Metz R., Prendergast G. C., Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate Cancer Research 2010 70 5 1845 1853
54. Sharda D. R., Yu S., Ray M., Squadrito M. L., De Palma M., Wynn T. A., Morris Jr. S. M., Hankey P. A., Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase Journal of Immunology 2011 187 5 2181 2192
55. Singer K., Gottfried E., Kreutz M., Mackensen A., Suppression of T-cell responses by tumor metabolites Cancer Immunology, Immunotherapy 2011 60 3 425 431
56. Platten M., Wick W., Weller M., Malignant glioma biology: role for TGF- in growth, motility, angiogenesis, and immune escape Microscopy Research and Technique 2001 52 4 401 410 (Pubitemid 32167828)
57. Wesolowska A., Kwiatkowska A., Slomnicki L., Dembinski M., Master A., Sliwa M., Franciszkiewicz K., Chouaib S., Kaminska B., Microglia-derived TGF- as an important regulator of glioblastoma invasionan inhibition of TGF- -dependent effects by shRNA against human TGF- type II receptor Oncogene 2008 27 7 918 930 (Pubitemid 351225378)
58. Wick W., Platten M., Weller M., Glioma cell invasion: regulation of metalloproteinase activity by TGF- Journal of Neuro-Oncology 2001 53 2 177 185 (Pubitemid 33034690)
59. Flavell R. A., Sanjabi S., Wrzesinski S. H., Licona-Limn P., The polarization of immune cells in the tumour environment by TGF 2 Nature Reviews Immunology 2010 10 8 554 567
60. Huettner C., Czub S., Kerkau S., Roggendorf W., Tonn J. C., Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro Anticancer Research 1997 17 5 3217 3224 (Pubitemid 27522273)
61. Wu A., Wei J., Kong L. Y., Wang Y., Priebe W., Qiao W., Sawaya R., Heimberger A. B., Glioma cancer stem cells induce immunosuppressive macrophages/microglia Neuro-Oncology 2010 12 11 1113 1125
62. Schreiber R. D., Old L. J., Smyth M. J., Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 2011 331 6024 1565 1570
63. Cameron F., Whiteside G., Perry C., Ipilimumab: first global approval Drugs 2011 71 8 1093 1104
64. May K. F. Jr., Gulley J. L., Drake C. G., Dranoff G., Kantoff P. W., Prostate cancer immunotherapy Clinical Cancer Research 2011 17 16 5233 5238
65. Robert C., Thomas L., Bondarenko I., O'Day S., Weber J., Garbe C., Lebbe C., Baurain J.-F., Testori A., Grob J.-J., Davidson N., Richards J., Maio M., Hauschild A., Miller Jr. W. H., Gascon P., Lotem M., Harmankaya K., Ibrahim R., Francis S., Chen T.-T., Humphrey R., Hoos A., Wolchok J. D., Ipilimumab plus dacarbazine for previously untreated metastatic melanoma The New England Journal of Medicine 2011 364 26 2517 2526
66. Parsa A. T., Waldron J. S., Panner A., Crane C. A., Parney I. F., Barry J. J., Cachola K. E., Murray J. C., Tihan T., Jensen M. C., Mischel P. S., Stokoe D., Pieper R. O., Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma Nature Medicine 2007 13 1 84 88 (Pubitemid 46067390)
67. Murdoch C., Muthana M., Coffelt S. B., Lewis C. E., The role of myeloid cells in the promotion of tumour angiogenesis Nature Reviews Cancer 2008 8 8 618 631
68. Qian B. Z., Pollard J. W., Macrophage diversity enhances tumor progression and metastasis Cell 2010 141 1 39 51
69. Ribechini E., Greifenberg V., Sandwick S., Lutz M. B., Subsets, expansion and activation of myeloid-derived suppressor cells Medical Microbiology Immunology 2010 199 3 273 281
70. Lechner M. G., Liebertz D. J., Epstein A. L., Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells Journal of Immunology 2010 185 4 2273 2284
71. Biswas S. K., Mantovani A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm Nature Immunology 2010 11 10 889 896
72. Yang I., Han S. J., Kaur G., Crane C., Parsa A. T., The role of microglia in central nervous system immunity and glioma immunology Journal of Clinical Neuroscience 2010 17 1 6 10
73. Ma Y., Aymeric L., Locher C., Kroemer G., Zitvogel L., The dendritic cell-tumor cross-talk in cancer Current Opinion in Immunology 2011 23 1 146 152
74. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., Sorg C., Macrophages and angiogenesis Journal of Leukocyte Biology 1994 55 3 410 422 (Pubitemid 24097250)
75. Lund A. W., Swartz M. A., Role of lymphatic vessels in tumor immunity: passive conduits or active participants? Journal of Mammary Gland Biology and Neoplasia 2010 15 3 341 352
76. Wu N. Z., Klitzman B., Dodge R., Dewhirst M. W., Diminished leukocyte-endothelium interaction in tumor microvessels Cancer Research 1992 52 15 4265 4268
77. Zadeh G., Koushan K., Pillo L., Shannon P., Guha A., Role of Ang1 and its interaction with VEGF-A in astrocytomas Journal of Neuropathology and Experimental Neurology 2004 63 9 978 989 (Pubitemid 39202500)
78. Brunckhorst M. K., Wang H., Lu R., Yu Q., Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis Cancer Research 2010 70 18 7283 7293
79. Debinski W., Slagle-Webb B., Achen M. G., Stacker S. A., Tulchinsky E., Gillespie G. Y., Gibo D. M., VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme Molecular Medicine 2001 7 9 598 608 (Pubitemid 34175288)
80. Terry L. A., Usherwood E. J., Lees S., Macintyre N., Nash A. A., Immune response to murine cell lines of glial origin transplanted into the central nervous system of adult mice Immunology 1997 91 3 436 443 (Pubitemid 27304280)
81. Liau L. M., Prins R. M., Kiertscher S. M., Odesa S. K., Kremen T. J., Giovannone A. J., Lin J. W., Chute D. J., Mischet P. S., Cloughesy T. F., Roth M. D., Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clinical Cancer Research 2005 11 15 5515 5525 (Pubitemid 41060828)
82. Sampson J. H., Aldape K. D., Archer G. E., Coan A., Desjardins A., Friedman A. H., Friedman H. S., Gilbert M. R., Herndon J. E., McLendon R. E., Mitchell D. A., Reardon D. A., Sawaya R., Schmittling R., Shi W., Vredenburgh J. J., Bigner D. D., Heimberger A. B., Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma Neuro-Oncology 2011 13 3 324 333
83. Zhai H., Heppner F. L., Tsirka S. E., Microglia/macrophages promote glioma progression GLIA 2011 59 472 485
84. Engelhardt B., Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines Journal of the Neurological Sciences 2008 274 1-2 23 26
85. Engelhardt B., Wolburg H., Mini review: transendothelial migration of leukocytes: through the front door or around the side of the house? European Journal of Immunology 2004 34 11 2955 2963 (Pubitemid 39549374)
86. Medawar P. B., Immunity to homologous grafted skin; the fate of skin homografts British Journal of Experimental Pathology 1948 29 1 58 69
87. Kraman M., Bambrough P. J., Arnold J. N., Roberts E. W., Magiera L., Jones J. O., Gopinathan A., Tuveson D. A., Fearon D. T., Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein- Science 2010 330 6005 827 830
88. Shields J. D., Kourtis I. C., Tomei A. A., Roberts J. M., Swartz M. A., Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21 Science 2010 328 5979 749 752
89. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T., Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography Journal of Nuclear Medicine 1992 33 11 1972 1980
90. Biegel J. A., Cytogenetics and molecular genetics of childhood brain tumors Neuro-Oncology 1999 1 2 139 151
91. Sanson M., Thillet J., Hoang-Xuan K., Molecular changes in gliomas Current Opinion in Oncology 2004 16 6 607 613 (Pubitemid 39482982)
92. Speidel D., Transcription-independent p53 apoptosis: an alternative route to death Trends in Cell Biology 2010 20 1 14 24
93. Wechsler-Reya R., Scott M. P., The developmental biology of brain tumors Annual Review of Neuroscience 2001 24 385 428 (Pubitemid 32695234)
94. Llambi F., Green D. R., Apoptosis and oncogenesis: give and take in the BCL-2 family Current Opinion in Genetics and Development 2011 21 1 12 20
95. Zhou F., Yang Y., Xing D., Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis FEBS Journal 2011 278 3 403 413
96. Mills J. R., Hippo Y., Robert F., Chen S. M. H., Malina A., Lin C. J., Trojahn U., Wendel H. G., Charest A., Bronson R. T., Kogan S. C., Nadon R., Housman D. E., Lowe S. W., Pelletier J., mTORC1 promotes survival through translational control of Mcl-1 Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10853 10858
97. Schietinger A., Philip M., Schreiber H., Specificity in cancer immunotherapy Seminars in Immunology 2008 20 5 276 285
98. Duan F., Lin Y., Liu C., Engelhorn M. E., Cohen A. D., Curran M., Sakaguchi S., Merghoub T., Terzulli S., Wolchok J. D., Houghton A. N., Immune rejection of mouse tumors expressing Mutated self Cancer Research 2009 69 8 3545 3553
99. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation Nature 2008 454 7203 436 444
100. Movahedi K., Laoui D., Gysemans C., Baeten M., Stangé G., Van Bossche J. D., Mack M., Pipeleers D., In't Veld P., De Baetselier P., Van Ginderachter J. A., Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes Cancer Research 2010 70 14 5728 5739
101. Clark C. E., Beatty G. L., Vonderheide R. H., Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer Cancer Letters 2009 279 1 1 7
102. Willimsky G., Blankenstein T., Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance Nature 2005 437 7055 141 146 (Pubitemid 41613441)
103. Zhang B., Bowerman N. A., Salama J. K., Schmidt H., Spiotto M. T., Schietinger A., Yu P., Fu Y. X., Weichselbaum R. R., Rowley D. A., Kranz D. M., Schreiber H., Induced sensitization of tumor stroma leads to eradication of established cancer by T cells Journal of Experimental Medicine 2007 204 1 49 55 (Pubitemid 46148755)
104. Quezada S. A., Peggs K. S., Simpson T. R., Allison J. P., Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication Immunological Reviews 2011 241 1 104 118
105. Quezada S. A., Peggs K. S., Simpson T. R., Shen Y., Littman D. R., Allison J. P., Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma Journal of Experimental Medicine 2008 205 9 2125 2138
106. Schreiber H., Rowley D. A., Awakening immunity Science 2010 330 6005 761 762
107. Dunn J. R., Reed J. E., Du Plessis D. G., Shaw E. J., Reeves P., Gee A. L., Warnke P., Walker C., Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours British Journal of Cancer 2006 94 8 1186 1193
108. Fletcher A. L., Malhotra D., Turley S. J., Lymph node stroma broaden the peripheral tolerance paradigm Trends in Immunology 2011 32 1 12 18
109. He Z., Bateman A., Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis Journal of Molecular Medicine 2003 81 10 600 612 (Pubitemid 37357675)
110. Liau L. M., Lallone R. L., Seitz R. S., Buznikov A., Gregg J. P., Kornblurn H. I., Nelson S. F., Bronstein J. M., Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption Cancer Research 2000 60 5 1353 1360 (Pubitemid 30152006)
111. Han S. J., Kaur G., Yang I., Lim M., Biologic principles of immunotherapy for malignant gliomas Neurosurgery Clinics of North America 2010 21 1 1 16
112. Wermeling F., Karlsson M. C. I., McGaha T. L., An anatomical view on macrophages in tolerance Autoimmunity Reviews 2009 9 1 49 52
113. Asano K., Nabeyama A., Miyake Y., Qiu C. H., Kurita A., Tomura M., Kanagawa O., Fujii S. I., Tanaka M., CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens Immunity 2010 34 1 85 95
114. Giometto B., Bozza F., Faresin F., Alessio L., Mingrino S., Tavolato B., Immune infiltrates and cytokines in gliomas Acta Neurochirurgica 1996 138 1 50 56 (Pubitemid 26043363)
115. Merzak A., McCrea S., Koocheckpour S., Pilkington G. J., Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor 1 British Journal of Cancer 1994 70 2 199 203 (Pubitemid 24247137)
116. Zindl C. L., Chaplin D. D., Tumor immune evasion Science 2010 328 5979 697 698
117. Qualls J. E., Murray P. J., A double agent in cancer: stopping macrophages wounds tumors Nature Medicine 2010 16 863 864
118. Kluwe J., Mencin A., Schwabe R. F., Toll-like receptors, wound healing, and carcinogenesis Journal of Molecular Medicine 2009 87 2 125 138
119. Restifo N. P., Can antitumor immunity help to explain oncogene addiction? Cancer Cell 2010 18 5 403 405
120. Tseng D., Vasquez-Medrano D. A., Brown J. M., Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas British Journal of Cancer 2011 104 12 1805 1809
121. Frumento G., Piazza T., Di Carlo E., Ferrini S., Targeting tumor-related immunosuppression for cancer immunotherapy Endocrine, Metabolic and Immune DisordersDrug Targets 2006 6 3 223 237 (Pubitemid 44383206)
122. Green D. R., Ferguson T., Zitvogel L., Kroemer G., Immunogenic and tolerogenic cell death Nature Reviews Immunology 2009 9 5 353 363
123. de Visser K. E., Eichten A., Coussens L. M., Paradoxical roles of the immune system during cancer development Nature Reviews Cancer 2006 6 1 24 37 (Pubitemid 43053650)
124. Paupert J., Sounni N. E., Nol A., Lymphangiogenesis in post-natal tissue remodeling: lymphatic endothelial cell connection with its environment Molecular Aspects of Medicine 2011 32 2 146 158
125. Trajkovic V., Vuckovic O., Stosic-Grujicic S., Miljkovic D., Popadic D., Markovic M., Bumbasirevic V., Backovic A., Cvetkovic I., Harhaji L., Ramic Z., Stojkovic M. M., Astrocyte-induced regulatory T cells mitigate CNS autoimmunity GLIA 2004 47 2 168 179 (Pubitemid 39049990)
126. Mellor A. L., Munn D. H., Physiologic control of the functional status of Foxp3 + regulatory T cells Journal of Immunology 2011 186 8 4535 4540
127. Munn D. H., Sharma M. D., Hou D., Baban B., Lee J. R., Antonia S. J., Messina J. L., Chandler P., Koni P. A., Mellor A. L., Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes Journal of Clinical Investigation 2004 114 2 280 290 (Pubitemid 39071633)
128. Munn D. H., Sharma M. D., Mellor A. L., Ligation of B7-1/B7-2 by human CD4 + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells Journal of Immunology 2004 172 7 4100 4110 (Pubitemid 38375222)
129. Yan M. L., Wang Y. D., Tian Y. F., Lai Z. D., Yan L. N., Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase World Journal of Gastroenterology 2010 16 5 636 640
130. Soliman H., Mediavilla-Varela M., Antonia S., Indoleamine 2,3-dioxygenase is it an immune suppressor? Cancer Journal 2010 16 4 354 359
131. Yan Y., Zhang G. X., Gran B., Fallarino F., Yu S., Li H., Cullimore M. L., Rostami A., Xu H., IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in Experimental autoimmune encephalomyelitis Journal of Immunology 2010 185 10 5953 5961
132. Munn D. H., Sharma M. D., Baban B., Harding H. P., Zhang Y., Ron D., Mellor A. L., GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase Immunity 2005 22 5 633 642 (Pubitemid 40719198)
133. Mellor A. L., Munn D., Chandler P., Keskin D., Johnson T., Marshall B., Jhaver K., Baban B., Tryptophan catabolism and T cell responses Advances in Experimental Medicine and Biology 2003 527 27 35 (Pubitemid 38197625)
134. Sun Y., Chin Y. E., Weisiger E., Malter C., Tawara I., Toubai T., Gatza E., Mascagni P., Dinarello C. A., Reddy P., Cutting edge: negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3 Journal of Immunology 2009 182 10 5899 5903
135. Bonifazi P., Zelante T., D'Angelo C., De Luca A., Moretti S., Bozza S., Perruccio K., Iannitti R. G., Giovannini G., Volpi C., Fallarino F., Puccetti P., Romani L., Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans Mucosal Immunology 2009 2 4 362 374
136. Miyazaki T., Moritake K., Yamada K., Hara N., Osago H., Shibata T., Akiyama Y., Tsuchiya M., Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy: laboratory investigation Journal of Neurosurgery 2009 111 2 230 237
137. Moffett J. R., Els T., Espey M. G., Walter S. A., Streit W. J., Namboodiri M. A. A., Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes Experimental Neurology 1997 144 2 287 301 (Pubitemid 27224557)
138. Chen Y., Jing Z., Luo C., Zhuang M., Xia J., Chen Z., Wang Y., Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study. Medical Oncology. In Press
139. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., Maira G., Parati E. A., Stassi G., Larocca L. M., De Maria R., Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells Nature 2010 468 7325 824 830
140. Shaifer C. A., Huang J., Lin P. C., Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance International Journal of Cancer 2010 127 9 2063 2075
141. Virrey J. J., Golden E. B., Sivakumar W., Wang W., Pen L., Schnthal A. H., Hofman F. M., Chen T. C., Glioma-associated endothelial cells are chemoresistant to temozolomide Journal of Neuro-Oncology 2009 95 1 13 22
142. Wang R., Chadalavada K., Wilshire J., Kowalik U., Hovinga K. E., Geber A., Fligelman B., Leversha M., Brennan C., Tabar V., Glioblastoma stem-like cells give rise to tumour endothelium Nature 2010 468 7325 829 833
143. El Hallani S., Boisselier B., Peglion F., Rousseau A., Colin C., Idbaih A., Marie Y., Mokhtari K., Thomas J. L., Eichmann A., Delattre J. Y., Maniotis A. J., Sanson M., A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry Brain 2010 133 4 973 982
144. Prins R. M., Shu C. J., Radu C. G., Vo D. D., Khan-Farooqi H., Soto H., Yang M. -Y., Lin M. -S., Shelly S., Witte O. N., Ribas A., Liau L. M., Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain Cancer Immunology, Immunotherapy 2008 57 9 1279 1289
145. Cheever M. A., Twelve immunotherapy drugs that could cure cancers Immunological Reviews 2008 222 1 357 368 (Pubitemid 351430366)
146. Keunen O., Johansson M., Oudin A., Sanzey M., Rahim S. A.A., Fack F., Thorsen F., Taxt T., Bartos M., Jirik R., Miletic H., Wang J., Stieber D., Stuhr L., Moen I., Rygh C. B., Bjerkvig R., Niclou S. P., Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma Proceedings of the National Academy of Sciences of the United States of America 2011 108 9 3749 3754
147. Naik E., O'Reilly L. A., Asselin-Labat M. -L., Merino D., Lin A., Cook M., Coultas L., Bouillet P., Adams J. M., Strasser A., Destruction of tumor vasculature and abated tumor growth upon VEGF blockade is driven by proapoptotic protein Bim in endothelial cells Journal of Experimental Medicine 2011 208 7 1351 1358